186
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Stimulation of Schizophyllum commune Fruit Body Formation by Inhibitor of Membrane Function and Cell Wall Synthesis

&
Pages 1270-1274 | Received 07 Jan 1993, Published online: 12 Jun 2014
 

Abstract

The fruit body formation of Schizophyllum commune was greatly stimulated by the addition of papulacandin B, aculeacin A, gramicidin S, luteinizing hormone-releasing hormone (LH-RH), or digitonin to the culture media. Papulacandin B and aculeacin A inhibit glucan synthase, which was demonstrated with S. commune in vitro in this study. The in vitro S. commune glucan synthase was activated by phospholipids that counteracted the stimulation of fruit body formation by papulacandin B. LH-RH, however, did not inhibit the glucan synthase. Digitonin was known to inhibit chitin synthase, but polyoxin B, a substrate analogue inhibitor of chitin synthase, did not stimulate the fruit body formation. The characteristic common to most of these stimulators of fruit body formation is possible induction of structural changes of plasma membranes to which the substances can attach with their biphasic nature. These stimulators of fruit body formation were mostly accompanied by an evident suppression of hyphal growth, independent of phenoloxidase activity, and not observed in continuous dark or with monokaryotic strains.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.